StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > US$40 million Agreement

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Feb 15, 2021 3:38pm

130 Views

Post# 32569262

RE:RE:RE:RE:US$40 million Agreement

Its pretty simple really, if it didn't have an effect, these idiots wouldn't do it. They do it because I profits them, otherwise they wouldn't waste their time. The only people that want us to think the posts here make no difference are the same people that try to downplay the shorting on our stock, it's the very same people profiting from both and that's why they want it swept under the rug.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec